Literature DB >> 20606362

Endobronchial actinomycosis associated with a foreign body--successful short-term treatment with antibiotics--.

Kanako Maki1, Naofumi Shinagawa, Yasuyuki Nasuhara, Satoshi Oizumi, Hiromitsu Domen, Hironori Haga, Masaharu Nishimura.   

Abstract

Primary endobronchial actinomycosis is a very rare condition. We report herein the case of a healthy 66-year-old woman who presented with right lower lobe endobronchial actinomycosis associated with aspiration of a foreign body, which was presumed to be a fish bone swallowed 28 months previously. The patient achieved complete clinical and radiological recovery after removal of the foreign body and 1-month antibiotic therapy of oral amoxycillin. Our experience in the management of this patient should help clinicians to realize the importance of bronchoscopic investigation and the management of this rare but treatable condition.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20606362     DOI: 10.2169/internalmedicine.49.3475

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Endobronchial actinomycosis secondary to foreign body aspiration.

Authors:  Chi Shao; Peng Wang; Ruie Feng; Xuefeng Sun
Journal:  Infection       Date:  2016-10-15       Impact factor: 3.553

2.  Endobronchial actinomycosis: successful treatment with oral antibiotics.

Authors:  Nicole Skehan; Muhammad Naeem; Raja Vongala Reddy
Journal:  BMJ Case Rep       Date:  2015-12-17

3.  Primary Bronchopulmonary Actinomycosis Masquerading as Lung Cancer: Apropos of Two Cases and Literature Review.

Authors:  Stamatis Katsenos; Iosif Galinos; Panagiota Styliara; Nikoletta Galanopoulou; Konstantinos Psathakis
Journal:  Case Rep Infect Dis       Date:  2015-06-04

Review 4.  Actinomycosis: etiology, clinical features, diagnosis, treatment, and management.

Authors:  Florent Valour; Agathe Sénéchal; Céline Dupieux; Judith Karsenty; Sébastien Lustig; Pierre Breton; Arnaud Gleizal; Loïc Boussel; Frédéric Laurent; Evelyne Braun; Christian Chidiac; Florence Ader; Tristan Ferry
Journal:  Infect Drug Resist       Date:  2014-07-05       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.